These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575 [TBL] [Abstract][Full Text] [Related]
23. Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin. Karbassi M; Nikou S Arch Ophthalmol; 1995 Jun; 113(6):699-701. PubMed ID: 7786200 [No Abstract] [Full Text] [Related]
24. Another perspective on MAC prophylaxis. Interview by Gordon Nary. Pierce M J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):16-8. PubMed ID: 11362746 [TBL] [Abstract][Full Text] [Related]
25. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. Holmberg SD; Moorman AC; Von Bargen JC; Palella FJ; Loveless MO; Ward DJ; Navin TR JAMA; 1998 Feb; 279(5):384-6. PubMed ID: 9459473 [TBL] [Abstract][Full Text] [Related]
26. [Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS]. Gruschke A; Enzensberger R; Brade V Dtsch Med Wochenschr; 2002 Sep; 127(38):1947-50. PubMed ID: 12239654 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory opacities of the vitreous in rifabutin-associated uveitis. Chaknis MJ; Brooks SE; Mitchell KT; Marcus DM Am J Ophthalmol; 1996 Oct; 122(4):580-2. PubMed ID: 8862060 [TBL] [Abstract][Full Text] [Related]
28. Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. Vrioni G; Nauciel C; Kerharo G; Matsiota-Bernard P J Antimicrob Chemother; 1998 Oct; 42(4):483-7. PubMed ID: 9818747 [TBL] [Abstract][Full Text] [Related]
29. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Griffith DE; Brown-Elliott BA; Wallace RJ Clin Infect Dis; 2003 Nov; 37(9):1178-82. PubMed ID: 14557961 [TBL] [Abstract][Full Text] [Related]
30. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D; Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206 [TBL] [Abstract][Full Text] [Related]
31. MAC prophylaxis revisited. Torres G GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706 [TBL] [Abstract][Full Text] [Related]
32. Uveitis associated with rifabutin therapy: a clinical alert. Petrowski JT J Am Optom Assoc; 1996 Nov; 67(11):693-6. PubMed ID: 8979664 [TBL] [Abstract][Full Text] [Related]
37. [Managements of tuberculosis complicated with HIV infection and AIDS]. Xiao H; He G Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):659-62. PubMed ID: 11225028 [No Abstract] [Full Text] [Related]
38. Sarcoidosis-related anterior uveitis in a patient with human immunodeficiency virus. Lee AK; Chronister CL J Am Optom Assoc; 1999 Jun; 70(6):384-90. PubMed ID: 10437340 [TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection. Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA; Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762 [TBL] [Abstract][Full Text] [Related]
40. Rifamycin-resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: a report of 3 relapses with acquired rifampin resistance following alternate-day rifabutin and boosted protease inhibitor therapy. Jenny-Avital ER; Joseph K Clin Infect Dis; 2009 May; 48(10):1471-4. PubMed ID: 19368504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]